BRYSON STAIR: Open Payments
NPI 1245596238 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$638 in 22 payments from 10 companies in 2025. Trend: 2023 $326 · 2024 $229 · 2025 $638
Food & beverage: $638
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $237 |
| GENZYME CORPORATION | 1 | $137 |
| Viatris Specialty LLC | 2 | $48 |
| GlaxoSmithKline, LLC. | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Amgen Inc. | 2 | $35 |
| Insmed, Inc. | 2 | $30 |
| Verona Pharma, Inc. | 1 | $26 |
| Philips North America LLC | 1 | $20 |
| Vifor Pharma, Inc. | 1 | $18 |
Products named: TEZSPIRE, BREZTRI, YUPELRI, GLASSIA, FASENRA, Arikayce, TRELEGY ELLIPTA, Ohtuvayre.
Industry payments across OH — which companies pay providers there.
